SNT 0.00% 3.0¢ syntara limited

Ann: PHARMAXIS ANNOUNCES SUSTAINED BENEFIT WITH B, page-3

  1. 220 Posts.
    lightbulb Created with Sketch. 5
    re: Ann: PHARMAXIS ANNOUNCES SUSTAINED BENEFI... announcement is significant

    So what is next - 1) the release of a decision from the US FDA on approval of Aridol in late December 2009 and 2) release of results from the Phase Ia clinical trial for PXS25 for pulmonary fibrosis late in 4QCY09.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.0¢
Change
0.000(0.00%)
Mkt cap ! $35.82M
Open High Low Value Volume
3.0¢ 3.3¢ 3.0¢ $196.5K 6.494M

Buyers (Bids)

No. Vol. Price($)
2 224999 3.0¢
 

Sellers (Offers)

Price($) Vol. No.
3.2¢ 50000 1
View Market Depth
Last trade - 16.10pm 10/07/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.